JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on January 25, 2008
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
283/4/1985    most recent
M708160200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, E.
Right arrow Articles by Baenziger, J. U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, E.
Right arrow Articles by Baenziger, J. U.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print November 29, 2007
J. Biol. Chem, 10.1074/jbc.M708160200
Submitted on October 2, 2007
Revised on November 28, 2007
Accepted on November 29, 2007

A necessary and sufficient determinant for protein-selective glycosylation in vivo

Erin Miller, Dorothy Fiete, Nicquet M.J. Blake, Mary Beranek, Edward L. Oates, Yiling Mi, Daniel S. Roseman, and Jacques U. Baenziger

Pathology, Washington University, St. Louis, MO 63130

Corresponding Author: Baenziger{at}wustl.edu

A limited number of glycoproteins including luteinizing hormone (LH) and carbonic anhydrase-VI (CA6) bear N-linked oligosaccharides that are modified with beta 1,4-linked GalNAc. The selective addition of GalNAc to these glycoproteins requires that the beta 1,4-N-acetylgalactosaminyltransferase (beta GT) recognize both the oligosaccharide acceptor and a peptide-recognition determinant on the substrate glycoprotein. We report here that two recently cloned beta GTs, beta GT3 and beta GT4, that are able to transfer GalNAc to GlcNAc in beta 1,4-linkage display the necessary glycoprotein specificity in vivo. Both beta GTs transfer GalNAc to N-linked oligosaccharides on the LH alpha subunit and CA6 but not to those on transferrin (Trf). A single peptide recognition determinant encoded in the carboxy terminal 19 amino acid sequence of bovine CA6 mediates transfer of GalNAc to each of its two N-linked oligosaccharides. Addition of this 19 amino acid sequence to the carboxy terminus of Trf confers full acceptor activity onto Trf for both beta GT3 and beta GT4 in vivo. The complete 19 amino acid sequence is required for optimal GalNAc addition in vivo, indicating that the peptide sequence is both necessary and sufficient for recognition by beta GT3 and beta GT4.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
GlycobiologyHome page
Z. S Kawar, T. K Johnson, S. Natunen, J. B Lowe, and R. D Cummings
PSGL-1 from the murine leukocytic cell line WEHI-3 is enriched for core 2-based O-glycans with sialyl Lewis x antigen
Glycobiology, June 1, 2008; 18(6): 441 - 446.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.